Patterns of Diabetes Care Among People with Type 1 Diabetes During Ramadan: An International Prospective Study (DAR-MENA T1DM).
Adaptation, Physiological
Adult
Diabetes Complications
/ prevention & control
Diabetes Mellitus, Type 1
/ etiology
Diabetes Mellitus, Type 2
/ ethnology
Fasting
/ adverse effects
Female
Humans
Hyperglycemia
/ prevention & control
Hypoglycemic Agents
/ therapeutic use
Incidence
Islam
/ psychology
Male
Middle Aged
Patient Education as Topic
Prospective Studies
Epidemiology
Fasting
Hypoglycemia
Ramadan
Type 1 diabetes
Journal
Advances in therapy
ISSN: 1865-8652
Titre abrégé: Adv Ther
Pays: United States
ID NLM: 8611864
Informations de publication
Date de publication:
04 2020
04 2020
Historique:
received:
17
12
2019
pubmed:
8
3
2020
medline:
15
12
2020
entrez:
8
3
2020
Statut:
ppublish
Résumé
To describe the characteristics and care of participants with type 1 diabetes during Ramadan in the Middle East and North Africa. The DAR-MENA (Diabetes and Ramadan-Middle East and North Africa) study was a prospective, observational study of adults with type 1 and type 2 diabetes who were Muslim and did/did not intend to fast during Ramadan 2016. Baseline data were collected 6 weeks prior to Ramadan, with a follow-up visit 1-2 months after Ramadan. This is the analysis of the population with type 1 diabetes. Measurements included proportion who fasted, reasons for fasting and not fasting, changes in diabetes treatment, hypoglycemic events, and proportion with access to diabetes education. Of 136 participants with type 1 diabetes, 76.9% (100/130) fasted for at least 1 day, 72.3% (94/130) fasted for at least 15 days, and 48.5% (63/130) fasted for 30 days. The majority (63.0%, 63/100) reported personal decision as a reason to fast. Fear of diabetic complications (58.6%, 17/29) and previous complications related to fasting (48.3%, 14/29) were the most common reasons for not fasting. Adjustment of diabetic medication regimen occurred for 84.6% (115/136) of participants, and 72.8% (99/136) changed their treatment dose. The incidence and number of adverse events for confirmed and severe hypoglycemia were similar before and during Ramadan. Almost half of participants had access to diabetes education (45.6%, 62/136). The DAR-MENA study showed that despite the risks associated with fasting for people with type 1 diabetes, almost half fasted for the full 30 days of Ramadan with no significant change in hypoglycemia events. Since the current International Diabetes Federation and Diabetes and Ramadan guidelines do not endorse fasting for people with type 1 diabetes, it is important that those who insist on fasting work closely with their healthcare practitioner to avoid any complications.
Identifiants
pubmed: 32144714
doi: 10.1007/s12325-020-01267-4
pii: 10.1007/s12325-020-01267-4
pmc: PMC7140750
doi:
Substances chimiques
Hypoglycemic Agents
0
Types de publication
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Pagination
1550-1563Références
Qur’an. Surah al-Baqarah. 2:185.
Al-Arouj M, Bouguerra R, Buse J, et al. Recommendations for management of diabetes during Ramadan. Diabetes Care. 2005;28:2305–11.
doi: 10.2337/diacare.28.9.2305
Hassanein M, Al-Arouj M, Hamdy O, et al. Diabetes and Ramadan: practical guidelines. Diabetes Res Clin Pract. 2017;126:303–16.
doi: 10.1016/j.diabres.2017.03.003
Al-Arouj M, Assaad-Khalil S, Buse J, et al. Recommendations for management of diabetes during Ramadan: update 2010. Diabetes Care. 2010;33:1895–902.
doi: 10.2337/dc10-0896
Salti I, Benard E, Detournay B, et al. A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care. 2004;27:2306–11.
doi: 10.2337/diacare.27.10.2306
Hassanein M, Al Awadi FF, El Hadidy KES, et al. The characteristics and pattern of care for the type 2 diabetes mellitus population in the MENA region during Ramadan: an international prospective study (DAR-MENA T2DM). Diabetes Res Clin Pract. 2019;151:275–84.
doi: 10.1016/j.diabres.2019.02.020
Alamoudi R, Alsubaiee M, Alqarni A, et al. Attitudes and habits of patients with type 1 diabetes during fasting Ramadan. J Clin Transl Endocrinol. 2018;14:1–4.
pubmed: 30294552
pmcid: 6169503
Eid YM, Sahmoud SI, Abdelsalam MM, Eichorst B. Empowerment-based diabetes self-management education to maintain glycemic targets during Ramadan fasting in people with diabetes who are on conventional insulin: a feasibility study. Diabetes Spectr. 2017;30:36–42.
doi: 10.2337/ds15-0058
Reiter J, Wexler ID, Shehadeh N, Tzur A, Zangen D. Type 1 diabetes and prolonged fasting. Diabet Med. 2007;24:436–9.
doi: 10.1111/j.1464-5491.2007.02098.x
STROBE. STrengthening the Reporting of OBservational studies in Epidemiology. 2014. https://www.strobe-statement.org/index.php?id=strobe-home . Accessed Jul 2018.
Ahmedani MY, Hashmi BZ, Ulhaque MS. Ramadan and diabetes—knowledge, attitude and practices of general practitioners; a cross-sectional study. Pak J Med Sci. 2016;32:846–50.
pubmed: 27648026
pmcid: 5017089
Abid M, Hsairi M, Elleuch M, Ben Aissa E. Survey on diabetic patients treated with insulin during the fasting month of Ramadan. Int J Gen Med. 2018;11:33–40.
doi: 10.2147/IJGM.S131308
Alabbood MH, Ho KW, Simons MR. The effect of Ramadan fasting on glycaemic control in insulin dependent diabetic patients: a literature review. Diabetes Metab Syndr. 2017;11:83–7.
doi: 10.1016/j.dsx.2016.06.028
Ahmed MH, Husain NE, Elmadhoun WM, Noor SK, Khalil AA, Almobarak AO. Diabetes and Ramadan: a concise and practical update. J Family Med Prim Care. 2017;6:11–8.
doi: 10.4103/2249-4863.214964